Executive Moves James Rawls, PharmD, joins LB as SVP of regulatory affairs LB Pharmaceuticals (NASDAQ: LBRX) has announced the appointment of James Rawls, PharmD, as senior vice president (SVP) of regulatory affairs. With more than 25 years of regulatory leadership experience across global... October 14, 2025